Cerafill Retaliate
NDC Package 49967-760-01
Package Information
Cerafill Retaliate is a . Marketed by L'oreal Usa, Inc., this product is identified by NDC 49967-760 and is authorized under FDA application ANDA075518.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49967 - L'oreal Usa, Inc.
- 49967-760 - Cerafill Retaliate
- 49967-760-01 - 2 BOTTLE in 1 CARTON / 60 mL in 1 BOTTLE
- 49967-760 - Cerafill Retaliate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49967-760-01 identifies a specific commercial package of 2 bottle in 1 carton / 60 ml in 1 bottle of Cerafill Retaliate Extra Strength For Men, labeled by L'oreal Usa, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by L'oreal Usa, Inc. on April 28, 2014. The current certification is valid through April 30, 2018.
How is this L'oreal Usa, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49967076001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.